179 related articles for article (PubMed ID: 30860683)
21. Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse.
Stiborová M; Arlt VM; Henderson CJ; Wolf CR; Kotrbová V; Moserová M; Hudecek J; Phillips DH; Frei E
Toxicol Appl Pharmacol; 2008 Feb; 226(3):318-27. PubMed ID: 17976674
[TBL] [Abstract][Full Text] [Related]
22. Passive Diffusion vs Active pH-Dependent Encapsulation of Tyrosine Kinase Inhibitors Vandetanib and Lenvatinib into Folate-Targeted Ferritin Delivery System.
Skubalova Z; Rex S; Sukupova M; Zahalka M; Skladal P; Pribyl J; Michalkova H; Weerasekera A; Adam V; Heger Z
Int J Nanomedicine; 2021; 16():1-14. PubMed ID: 33442247
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of human cytochrome P450 3A4 present in liposomal and microsomal nanoparticles in formation of covalent DNA adducts by ellipticine.
Sulc M; Mrizova I; Cerna T; Frei E; Eckschlager T; Adam V; Kopeckova K; Stiborova M
Neuro Endocrinol Lett; 2016 Dec; 37(Suppl1):95-102. PubMed ID: 28263536
[TBL] [Abstract][Full Text] [Related]
24. Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells.
Starenki D; Hong SK; Wu PK; Park JI
Cancer Biol Ther; 2017 Jul; 18(7):473-483. PubMed ID: 28475408
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxicity of and DNA adduct formation by ellipticine in human U87MG glioblastoma cancer cells.
Martinkova E; Dontenwill M; Frei E; Stiborova M
Neuro Endocrinol Lett; 2009; 30 Suppl 1():60-6. PubMed ID: 20027146
[TBL] [Abstract][Full Text] [Related]
26. Antitumor drug ellipticine inhibits the activities of rat hepatic cytochromes P450.
Aimová D; Stiborová M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):437-40. PubMed ID: 16601806
[TBL] [Abstract][Full Text] [Related]
27. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
28. A Mechanism of O-Demethylation of Aristolochic Acid I by Cytochromes P450 and Their Contributions to This Reaction in Human and Rat Livers: Experimental and Theoretical Approaches.
Stiborová M; Bárta F; Levová K; Hodek P; Schmeiser HH; Arlt VM; Martínek V
Int J Mol Sci; 2015 Nov; 16(11):27561-75. PubMed ID: 26593908
[TBL] [Abstract][Full Text] [Related]
29. Oxidation of 3-aminobenzanthrone, a human metabolite of carcinogenic environmental pollutant 3-nitrobenzanthrone, by cytochromes P450 - similarity between human and rat enzymes.
Mizerovska J; Dracinska H; Arlt VM; Schmeiser HH; Frei E; Stiborova M
Neuro Endocrinol Lett; 2009; 30 Suppl 1():52-9. PubMed ID: 20027145
[TBL] [Abstract][Full Text] [Related]
30. Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid Cancer.
Koehler VF; Adam P; Frank-Raue K; Raue F; Berg E; Hoster E; Allelein S; Schott M; Kroiss M; Spitzweg C
Thyroid; 2021 Mar; 31(3):459-469. PubMed ID: 32781914
[No Abstract] [Full Text] [Related]
31. Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans.
Stiborová M; Stiborová-Rupertová M; Borek-Dohalská L; Wiessler M; Frei E
Chem Res Toxicol; 2003 Jan; 16(1):38-47. PubMed ID: 12693029
[TBL] [Abstract][Full Text] [Related]
32. Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitors.
Sandblom V; Spetz J; Shubbar E; Montelius M; Ståhl I; Swanpalmer J; Nilsson O; Forssell-Aronsson E
PLoS One; 2020; 15(5):e0233720. PubMed ID: 32459817
[TBL] [Abstract][Full Text] [Related]
33. Ellipticine and benzo(a)pyrene increase their own metabolic activation via modulation of expression and enzymatic activity of cytochromes P450 1A1 and 1A2.
Aimová D; Poljaková J; Kotrbová V; Moserová M; Frei E; Arlt VM; Stiborová M
Interdiscip Toxicol; 2008 Sep; 1(2):160-8. PubMed ID: 21218107
[TBL] [Abstract][Full Text] [Related]
34. Identification of Enzymes Oxidizing the Tyrosine Kinase Inhibitor Cabozantinib: Cabozantinib Is Predominantly Oxidized by CYP3A4 and Its Oxidation Is Stimulated by cyt b
Indra R; Vavrová K; Pompach P; Heger Z; Hodek P
Biomedicines; 2020 Nov; 8(12):. PubMed ID: 33260548
[TBL] [Abstract][Full Text] [Related]
35. Effects of cytochrome P450 inhibitors on peroxidase activity.
Martinkova M; Kubickova B; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():33-40. PubMed ID: 23353841
[TBL] [Abstract][Full Text] [Related]
36. DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P postlabeling.
Stiborová M; Breuer A; Aimová D; Stiborová-Rupertová M; Wiessler M; Frei E
Int J Cancer; 2003 Dec; 107(6):885-90. PubMed ID: 14601046
[TBL] [Abstract][Full Text] [Related]
37. Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model.
Tappenden P; Carroll C; Hamilton J; Kaltenthaler E; Wong R; Wadsley J; Moss L; Balasubramanian S
Health Technol Assess; 2019 Feb; 23(8):1-144. PubMed ID: 30821231
[TBL] [Abstract][Full Text] [Related]
38. Vandetanib versus Cabozantinib in Medullary Thyroid Carcinoma: A Focus on Anti-Angiogenic Effects in Zebrafish Model.
Carra S; Gaudenzi G; Dicitore A; Saronni D; Cantone MC; Plebani A; Ghilardi A; Borghi MO; Hofland LJ; Persani L; Vitale G
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809722
[TBL] [Abstract][Full Text] [Related]
39. The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts.
Stiborová M; Bieler CA; Wiessler M; Frei E
Biochem Pharmacol; 2001 Dec; 62(12):1675-84. PubMed ID: 11755121
[TBL] [Abstract][Full Text] [Related]
40. Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells.
Rodríguez-Hernández MA; Chapresto-Garzón R; Cadenas M; Navarro-Villarán E; Negrete M; Gómez-Bravo MA; Victor VM; Padillo FJ; Muntané J
Cell Death Dis; 2020 May; 11(5):339. PubMed ID: 32382022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]